Global Xerostomia (Dry Mouth) Therapeutics Market Research Report 2017

December 2017 | 116 pages | ID: G07BB22E812EN
QYResearch

Abstracts

In this report, the global Xerostomia (Dry Mouth) Therapeutics market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Xerostomia (Dry Mouth) Therapeutics in these regions, from 2012 to 2022 (forecast), covering

• North America
• Europe
• China
• Japan
• Southeast Asia
• India

Global Xerostomia (Dry Mouth) Therapeutics market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including

• GlaxoSmithKline plc
• Church & Dwight Co., Inc.
• Colgate-Palmolive Company
• Hikma Pharmaceuticals PLC
• Pendopharm
• Sun Pharmaceuticals Industries Ltd.
• Lupin Pharmaceuticals, Inc.
• Pfizer, Inc.
• Parnell Pharmaceuticals, Inc.
• Acacia Pharma
• OraCoat

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Salivary Stimulants
• Salivary Substitutes
• Dentifrices

On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including

• OTC
• Prescription

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

Global Xerostomia (Dry Mouth) Therapeutics Market Research Report 2017

1 XEROSTOMIA (DRY MOUTH) THERAPEUTICS MARKET OVERVIEW

1.1 Product Overview and Scope of Xerostomia (Dry Mouth) Therapeutics
1.2 Xerostomia (Dry Mouth) Therapeutics Segment by Type (Product Category)
  1.2.1 Global Xerostomia (Dry Mouth) Therapeutics Production and CAGR (%) Comparison by Type (Product Category)(2012-2022)
  1.2.2 Global Xerostomia (Dry Mouth) Therapeutics Production Market Share by Type (Product Category) in 2016
  1.2.3 Salivary Stimulants
  1.2.4 Salivary Substitutes
  1.2.5 Dentifrices
1.3 Global Xerostomia (Dry Mouth) Therapeutics Segment by Application
  1.3.1 Xerostomia (Dry Mouth) Therapeutics Consumption (Sales) Comparison by Application (2012-2022)
  1.3.2 OTC
  1.3.3 Prescription
1.4 Global Xerostomia (Dry Mouth) Therapeutics Market by Region (2012-2022)
  1.4.1 Global Xerostomia (Dry Mouth) Therapeutics Market Size (Value) and CAGR (%) Comparison by Region (2012-2022)
  1.4.2 North America Status and Prospect (2012-2022)
  1.4.3 Europe Status and Prospect (2012-2022)
  1.4.4 China Status and Prospect (2012-2022)
  1.4.5 Japan Status and Prospect (2012-2022)
  1.4.6 Southeast Asia Status and Prospect (2012-2022)
  1.4.7 India Status and Prospect (2012-2022)
1.5 Global Market Size (Value) of Xerostomia (Dry Mouth) Therapeutics (2012-2022)
  1.5.1 Global Xerostomia (Dry Mouth) Therapeutics Revenue Status and Outlook (2012-2022)
  1.5.2 Global Xerostomia (Dry Mouth) Therapeutics Capacity, Production Status and Outlook (2012-2022)

2 GLOBAL XEROSTOMIA (DRY MOUTH) THERAPEUTICS MARKET COMPETITION BY MANUFACTURERS

2.1 Global Xerostomia (Dry Mouth) Therapeutics Capacity, Production and Share by Manufacturers (2012-2017)
  2.1.1 Global Xerostomia (Dry Mouth) Therapeutics Capacity and Share by Manufacturers (2012-2017)
  2.1.2 Global Xerostomia (Dry Mouth) Therapeutics Production and Share by Manufacturers (2012-2017)
2.2 Global Xerostomia (Dry Mouth) Therapeutics Revenue and Share by Manufacturers (2012-2017)
2.3 Global Xerostomia (Dry Mouth) Therapeutics Average Price by Manufacturers (2012-2017)
2.4 Manufacturers Xerostomia (Dry Mouth) Therapeutics Manufacturing Base Distribution, Sales Area and Product Type
2.5 Xerostomia (Dry Mouth) Therapeutics Market Competitive Situation and Trends
  2.5.1 Xerostomia (Dry Mouth) Therapeutics Market Concentration Rate
  2.5.2 Xerostomia (Dry Mouth) Therapeutics Market Share of Top 3 and Top 5 Manufacturers
  2.5.3 Mergers & Acquisitions, Expansion

3 GLOBAL XEROSTOMIA (DRY MOUTH) THERAPEUTICS CAPACITY, PRODUCTION, REVENUE (VALUE) BY REGION (2012-2017)

3.1 Global Xerostomia (Dry Mouth) Therapeutics Capacity and Market Share by Region (2012-2017)
3.2 Global Xerostomia (Dry Mouth) Therapeutics Production and Market Share by Region (2012-2017)
3.3 Global Xerostomia (Dry Mouth) Therapeutics Revenue (Value) and Market Share by Region (2012-2017)
3.4 Global Xerostomia (Dry Mouth) Therapeutics Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.5 North America Xerostomia (Dry Mouth) Therapeutics Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.6 Europe Xerostomia (Dry Mouth) Therapeutics Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.7 China Xerostomia (Dry Mouth) Therapeutics Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.8 Japan Xerostomia (Dry Mouth) Therapeutics Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.9 Southeast Asia Xerostomia (Dry Mouth) Therapeutics Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.10 India Xerostomia (Dry Mouth) Therapeutics Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

4 GLOBAL XEROSTOMIA (DRY MOUTH) THERAPEUTICS SUPPLY (PRODUCTION), CONSUMPTION, EXPORT, IMPORT BY REGION (2012-2017)

4.1 Global Xerostomia (Dry Mouth) Therapeutics Consumption by Region (2012-2017)
4.2 North America Xerostomia (Dry Mouth) Therapeutics Production, Consumption, Export, Import (2012-2017)
4.3 Europe Xerostomia (Dry Mouth) Therapeutics Production, Consumption, Export, Import (2012-2017)
4.4 China Xerostomia (Dry Mouth) Therapeutics Production, Consumption, Export, Import (2012-2017)
4.5 Japan Xerostomia (Dry Mouth) Therapeutics Production, Consumption, Export, Import (2012-2017)
4.6 Southeast Asia Xerostomia (Dry Mouth) Therapeutics Production, Consumption, Export, Import (2012-2017)
4.7 India Xerostomia (Dry Mouth) Therapeutics Production, Consumption, Export, Import (2012-2017)

5 GLOBAL XEROSTOMIA (DRY MOUTH) THERAPEUTICS PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

5.1 Global Xerostomia (Dry Mouth) Therapeutics Production and Market Share by Type (2012-2017)
5.2 Global Xerostomia (Dry Mouth) Therapeutics Revenue and Market Share by Type (2012-2017)
5.3 Global Xerostomia (Dry Mouth) Therapeutics Price by Type (2012-2017)
5.4 Global Xerostomia (Dry Mouth) Therapeutics Production Growth by Type (2012-2017)

6 GLOBAL XEROSTOMIA (DRY MOUTH) THERAPEUTICS MARKET ANALYSIS BY APPLICATION

6.1 Global Xerostomia (Dry Mouth) Therapeutics Consumption and Market Share by Application (2012-2017)
6.2 Global Xerostomia (Dry Mouth) Therapeutics Consumption Growth Rate by Application (2012-2017)
6.3 Market Drivers and Opportunities
  6.3.1 Potential Applications
  6.3.2 Emerging Markets/Countries

7 GLOBAL XEROSTOMIA (DRY MOUTH) THERAPEUTICS MANUFACTURERS PROFILES/ANALYSIS

7.1 GlaxoSmithKline plc
  7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.1.2 Xerostomia (Dry Mouth) Therapeutics Product Category, Application and Specification
    7.1.2.1 Product A
    7.1.2.2 Product B
  7.1.3 GlaxoSmithKline plc Xerostomia (Dry Mouth) Therapeutics Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.1.4 Main Business/Business Overview
7.2 Church & Dwight Co., Inc.
  7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.2.2 Xerostomia (Dry Mouth) Therapeutics Product Category, Application and Specification
    7.2.2.1 Product A
    7.2.2.2 Product B
  7.2.3 Church & Dwight Co., Inc. Xerostomia (Dry Mouth) Therapeutics Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.2.4 Main Business/Business Overview
7.3 Colgate-Palmolive Company
  7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.3.2 Xerostomia (Dry Mouth) Therapeutics Product Category, Application and Specification
    7.3.2.1 Product A
    7.3.2.2 Product B
  7.3.3 Colgate-Palmolive Company Xerostomia (Dry Mouth) Therapeutics Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.3.4 Main Business/Business Overview
7.4 Hikma Pharmaceuticals PLC
  7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.4.2 Xerostomia (Dry Mouth) Therapeutics Product Category, Application and Specification
    7.4.2.1 Product A
    7.4.2.2 Product B
  7.4.3 Hikma Pharmaceuticals PLC Xerostomia (Dry Mouth) Therapeutics Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.4.4 Main Business/Business Overview
7.5 Pendopharm
  7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.5.2 Xerostomia (Dry Mouth) Therapeutics Product Category, Application and Specification
    7.5.2.1 Product A
    7.5.2.2 Product B
  7.5.3 Pendopharm Xerostomia (Dry Mouth) Therapeutics Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.5.4 Main Business/Business Overview
7.6 Sun Pharmaceuticals Industries Ltd.
  7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.6.2 Xerostomia (Dry Mouth) Therapeutics Product Category, Application and Specification
    7.6.2.1 Product A
    7.6.2.2 Product B
  7.6.3 Sun Pharmaceuticals Industries Ltd. Xerostomia (Dry Mouth) Therapeutics Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.6.4 Main Business/Business Overview
7.7 Lupin Pharmaceuticals, Inc.
  7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.7.2 Xerostomia (Dry Mouth) Therapeutics Product Category, Application and Specification
    7.7.2.1 Product A
    7.7.2.2 Product B
  7.7.3 Lupin Pharmaceuticals, Inc. Xerostomia (Dry Mouth) Therapeutics Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.7.4 Main Business/Business Overview
7.8 Pfizer, Inc.
  7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.8.2 Xerostomia (Dry Mouth) Therapeutics Product Category, Application and Specification
    7.8.2.1 Product A
    7.8.2.2 Product B
  7.8.3 Pfizer, Inc. Xerostomia (Dry Mouth) Therapeutics Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.8.4 Main Business/Business Overview
7.9 Parnell Pharmaceuticals, Inc.
  7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.9.2 Xerostomia (Dry Mouth) Therapeutics Product Category, Application and Specification
    7.9.2.1 Product A
    7.9.2.2 Product B
  7.9.3 Parnell Pharmaceuticals, Inc. Xerostomia (Dry Mouth) Therapeutics Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.9.4 Main Business/Business Overview
7.10 Acacia Pharma
  7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.10.2 Xerostomia (Dry Mouth) Therapeutics Product Category, Application and Specification
    7.10.2.1 Product A
    7.10.2.2 Product B
  7.10.3 Acacia Pharma Xerostomia (Dry Mouth) Therapeutics Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.10.4 Main Business/Business Overview
7.11 OraCoat

8 XEROSTOMIA (DRY MOUTH) THERAPEUTICS MANUFACTURING COST ANALYSIS

8.1 Xerostomia (Dry Mouth) Therapeutics Key Raw Materials Analysis
  8.1.1 Key Raw Materials
  8.1.2 Price Trend of Key Raw Materials
  8.1.3 Key Suppliers of Raw Materials
  8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
  8.2.1 Raw Materials
  8.2.2 Labor Cost
  8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Xerostomia (Dry Mouth) Therapeutics

9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

9.1 Xerostomia (Dry Mouth) Therapeutics Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Xerostomia (Dry Mouth) Therapeutics Major Manufacturers in 2015
9.4 Downstream Buyers

10 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

11 MARKET EFFECT FACTORS ANALYSIS

11.1 Technology Progress/Risk
  11.1.1 Substitutes Threat
  11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 GLOBAL XEROSTOMIA (DRY MOUTH) THERAPEUTICS MARKET FORECAST (2017-2022)

12.1 Global Xerostomia (Dry Mouth) Therapeutics Capacity, Production, Revenue Forecast (2017-2022)
  12.1.1 Global Xerostomia (Dry Mouth) Therapeutics Capacity, Production and Growth Rate Forecast (2017-2022)
  12.1.2 Global Xerostomia (Dry Mouth) Therapeutics Revenue and Growth Rate Forecast (2017-2022)
  12.1.3 Global Xerostomia (Dry Mouth) Therapeutics Price and Trend Forecast (2017-2022)
12.2 Global Xerostomia (Dry Mouth) Therapeutics Production, Consumption, Import and Export Forecast by Region (2017-2022)
  12.2.1 North America Xerostomia (Dry Mouth) Therapeutics Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.2 Europe Xerostomia (Dry Mouth) Therapeutics Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.3 China Xerostomia (Dry Mouth) Therapeutics Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.4 Japan Xerostomia (Dry Mouth) Therapeutics Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.5 Southeast Asia Xerostomia (Dry Mouth) Therapeutics Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.6 India Xerostomia (Dry Mouth) Therapeutics Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.3 Global Xerostomia (Dry Mouth) Therapeutics Production, Revenue and Price Forecast by Type (2017-2022)
12.4 Global Xerostomia (Dry Mouth) Therapeutics Consumption Forecast by Application (2017-2022)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

14.1 Methodology/Research Approach
  14.1.1 Research Programs/Design
  14.1.2 Market Size Estimation
  14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
  14.2.1 Secondary Sources
  14.2.2 Primary Sources
14.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Xerostomia (Dry Mouth) Therapeutics
Figure Global Xerostomia (Dry Mouth) Therapeutics Production (K Units) and CAGR (%) Comparison by Types (Product Category) (2012-2022)
Figure Global Xerostomia (Dry Mouth) Therapeutics Production Market Share by Types (Product Category) in 2016
Figure Product Picture of Salivary Stimulants
Table Major Manufacturers of Salivary Stimulants
Figure Product Picture of Salivary Substitutes
Table Major Manufacturers of Salivary Substitutes
Figure Product Picture of Dentifrices
Table Major Manufacturers of Dentifrices
Figure Global Xerostomia (Dry Mouth) Therapeutics Consumption (K Units) by Applications (2012-2022)
Figure Global Xerostomia (Dry Mouth) Therapeutics Consumption Market Share by Applications in 2016
Figure OTC Examples
Table Key Downstream Customer in OTC
Figure Prescription Examples
Table Key Downstream Customer in Prescription
Figure Global Xerostomia (Dry Mouth) Therapeutics Market Size (Million USD), Comparison (K Units) and CAGR (%) by Regions (2012-2022)
Figure North America Xerostomia (Dry Mouth) Therapeutics Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Xerostomia (Dry Mouth) Therapeutics Revenue (Million USD) and Growth Rate (2012-2022)
Figure China Xerostomia (Dry Mouth) Therapeutics Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan Xerostomia (Dry Mouth) Therapeutics Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia Xerostomia (Dry Mouth) Therapeutics Revenue (Million USD) and Growth Rate (2012-2022)
Figure India Xerostomia (Dry Mouth) Therapeutics Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global Xerostomia (Dry Mouth) Therapeutics Revenue (Million USD) Status and Outlook (2012-2022)
Figure Global Xerostomia (Dry Mouth) Therapeutics Capacity, Production (K Units) Status and Outlook (2012-2022)
Figure Global Xerostomia (Dry Mouth) Therapeutics Major Players Product Capacity (K Units) (2012-2017)
Table Global Xerostomia (Dry Mouth) Therapeutics Capacity (K Units) of Key Manufacturers (2012-2017)
Table Global Xerostomia (Dry Mouth) Therapeutics Capacity Market Share of Key Manufacturers (2012-2017)
Figure Global Xerostomia (Dry Mouth) Therapeutics Capacity (K Units) of Key Manufacturers in 2016
Figure Global Xerostomia (Dry Mouth) Therapeutics Capacity (K Units) of Key Manufacturers in 2017
Figure Global Xerostomia (Dry Mouth) Therapeutics Major Players Product Production (K Units) (2012-2017)
Table Global Xerostomia (Dry Mouth) Therapeutics Production (K Units) of Key Manufacturers (2012-2017)
Table Global Xerostomia (Dry Mouth) Therapeutics Production Share by Manufacturers (2012-2017)
Figure 2016 Xerostomia (Dry Mouth) Therapeutics Production Share by Manufacturers
Figure 2017 Xerostomia (Dry Mouth) Therapeutics Production Share by Manufacturers
Figure Global Xerostomia (Dry Mouth) Therapeutics Major Players Product Revenue (Million USD) (2012-2017)
Table Global Xerostomia (Dry Mouth) Therapeutics Revenue (Million USD) by Manufacturers (2012-2017)
Table Global Xerostomia (Dry Mouth) Therapeutics Revenue Share by Manufacturers (2012-2017)
Table 2016 Global Xerostomia (Dry Mouth) Therapeutics Revenue Share by Manufacturers
Table 2017 Global Xerostomia (Dry Mouth) Therapeutics Revenue Share by Manufacturers
Table Global Market Xerostomia (Dry Mouth) Therapeutics Average Price (USD/Unit) of Key Manufacturers (2012-2017)
Figure Global Market Xerostomia (Dry Mouth) Therapeutics Average Price (USD/Unit) of Key Manufacturers in 2016
Table Manufacturers Xerostomia (Dry Mouth) Therapeutics Manufacturing Base Distribution and Sales Area
Table Manufacturers Xerostomia (Dry Mouth) Therapeutics Product Category
Figure Xerostomia (Dry Mouth) Therapeutics Market Share of Top 3 Manufacturers
Figure Xerostomia (Dry Mouth) Therapeutics Market Share of Top 5 Manufacturers
Table Global Xerostomia (Dry Mouth) Therapeutics Capacity (K Units) by Region (2012-2017)
Figure Global Xerostomia (Dry Mouth) Therapeutics Capacity Market Share by Region (2012-2017)
Figure Global Xerostomia (Dry Mouth) Therapeutics Capacity Market Share by Region (2012-2017)
Figure 2016 Global Xerostomia (Dry Mouth) Therapeutics Capacity Market Share by Region
Table Global Xerostomia (Dry Mouth) Therapeutics Production by Region (2012-2017)
Figure Global Xerostomia (Dry Mouth) Therapeutics Production (K Units) by Region (2012-2017)
Figure Global Xerostomia (Dry Mouth) Therapeutics Production Market Share by Region (2012-2017)
Figure 2016 Global Xerostomia (Dry Mouth) Therapeutics Production Market Share by Region
Table Global Xerostomia (Dry Mouth) Therapeutics Revenue (Million USD) by Region (2012-2017)
Table Global Xerostomia (Dry Mouth) Therapeutics Revenue Market Share by Region (2012-2017)
Figure Global Xerostomia (Dry Mouth) Therapeutics Revenue Market Share by Region (2012-2017)
Table 2016 Global Xerostomia (Dry Mouth) Therapeutics Revenue Market Share by Region
Figure Global Xerostomia (Dry Mouth) Therapeutics Capacity, Production (K Units) and Growth Rate (2012-2017)
Table Global Xerostomia (Dry Mouth) Therapeutics Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Table North America Xerostomia (Dry Mouth) Therapeutics Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Table Europe Xerostomia (Dry Mouth) Therapeutics Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Table China Xerostomia (Dry Mouth) Therapeutics Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Table Japan Xerostomia (Dry Mouth) Therapeutics Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Table Southeast Asia Xerostomia (Dry Mouth) Therapeutics Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Table India Xerostomia (Dry Mouth) Therapeutics Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Table Global Xerostomia (Dry Mouth) Therapeutics Consumption (K Units) Market by Region (2012-2017)
Table Global Xerostomia (Dry Mouth) Therapeutics Consumption Market Share by Region (2012-2017)
Figure Global Xerostomia (Dry Mouth) Therapeutics Consumption Market Share by Region (2012-2017)
Figure 2016 Global Xerostomia (Dry Mouth) Therapeutics Consumption (K Units) Market Share by Region
Table North America Xerostomia (Dry Mouth) Therapeutics Production, Consumption, Import & Export (K Units) (2012-2017)
Table Europe Xerostomia (Dry Mouth) Therapeutics Production, Consumption, Import & Export (K Units) (2012-2017)
Table China Xerostomia (Dry Mouth) Therapeutics Production, Consumption, Import & Export (K Units) (2012-2017)
Table Japan Xerostomia (Dry Mouth) Therapeutics Production, Consumption, Import & Export (K Units) (2012-2017)
Table Southeast Asia Xerostomia (Dry Mouth) Therapeutics Production, Consumption, Import & Export (K Units) (2012-2017)
Table India Xerostomia (Dry Mouth) Therapeutics Production, Consumption, Import & Export (K Units) (2012-2017)
Table Global Xerostomia (Dry Mouth) Therapeutics Production (K Units) by Type (2012-2017)
Table Global Xerostomia (Dry Mouth) Therapeutics Production Share by Type (2012-2017)
Figure Production Market Share of Xerostomia (Dry Mouth) Therapeutics by Type (2012-2017)
Figure 2016 Production Market Share of Xerostomia (Dry Mouth) Therapeutics by Type
Table Global Xerostomia (Dry Mouth) Therapeutics Revenue (Million USD) by Type (2012-2017)
Table Global Xerostomia (Dry Mouth) Therapeutics Revenue Share by Type (2012-2017)
Figure Production Revenue Share of Xerostomia (Dry Mouth) Therapeutics by Type (2012-2017)
Figure 2016 Revenue Market Share of Xerostomia (Dry Mouth) Therapeutics by Type
Table Global Xerostomia (Dry Mouth) Therapeutics Price (USD/Unit) by Type (2012-2017)
Figure Global Xerostomia (Dry Mouth) Therapeutics Production Growth by Type (2012-2017)
Table Global Xerostomia (Dry Mouth) Therapeutics Consumption (K Units) by Application (2012-2017)
Table Global Xerostomia (Dry Mouth) Therapeutics Consumption Market Share by Application (2012-2017)
Figure Global Xerostomia (Dry Mouth) Therapeutics Consumption Market Share by Applications (2012-2017)
Figure Global Xerostomia (Dry Mouth) Therapeutics Consumption Market Share by Application in 2016
Table Global Xerostomia (Dry Mouth) Therapeutics Consumption Growth Rate by Application (2012-2017)
Figure Global Xerostomia (Dry Mouth) Therapeutics Consumption Growth Rate by Application (2012-2017)
Table GlaxoSmithKline plc Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table GlaxoSmithKline plc Xerostomia (Dry Mouth) Therapeutics Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure GlaxoSmithKline plc Xerostomia (Dry Mouth) Therapeutics Production Growth Rate (2012-2017)
Figure GlaxoSmithKline plc Xerostomia (Dry Mouth) Therapeutics Production Market Share (2012-2017)
Figure GlaxoSmithKline plc Xerostomia (Dry Mouth) Therapeutics Revenue Market Share (2012-2017)
Table Church & Dwight Co., Inc. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Church & Dwight Co., Inc. Xerostomia (Dry Mouth) Therapeutics Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Church & Dwight Co., Inc. Xerostomia (Dry Mouth) Therapeutics Production Growth Rate (2012-2017)
Figure Church & Dwight Co., Inc. Xerostomia (Dry Mouth) Therapeutics Production Market Share (2012-2017)
Figure Church & Dwight Co., Inc. Xerostomia (Dry Mouth) Therapeutics Revenue Market Share (2012-2017)
Table Colgate-Palmolive Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Colgate-Palmolive Company Xerostomia (Dry Mouth) Therapeutics Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Colgate-Palmolive Company Xerostomia (Dry Mouth) Therapeutics Production Growth Rate (2012-2017)
Figure Colgate-Palmolive Company Xerostomia (Dry Mouth) Therapeutics Production Market Share (2012-2017)
Figure Colgate-Palmolive Company Xerostomia (Dry Mouth) Therapeutics Revenue Market Share (2012-2017)
Table Hikma Pharmaceuticals PLC Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Hikma Pharmaceuticals PLC Xerostomia (Dry Mouth) Therapeutics Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Hikma Pharmaceuticals PLC Xerostomia (Dry Mouth) Therapeutics Production Growth Rate (2012-2017)
Figure Hikma Pharmaceuticals PLC Xerostomia (Dry Mouth) Therapeutics Production Market Share (2012-2017)
Figure Hikma Pharmaceuticals PLC Xerostomia (Dry Mouth) Therapeutics Revenue Market Share (2012-2017)
Table Pendopharm Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Pendopharm Xerostomia (Dry Mouth) Therapeutics Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Pendopharm Xerostomia (Dry Mouth) Therapeutics Production Growth Rate (2012-2017)
Figure Pendopharm Xerostomia (Dry Mouth) Therapeutics Production Market Share (2012-2017)
Figure Pendopharm Xerostomia (Dry Mouth) Therapeutics Revenue Market Share (2012-2017)
Table Sun Pharmaceuticals Industries Ltd. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Sun Pharmaceuticals Industries Ltd. Xerostomia (Dry Mouth) Therapeutics Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Sun Pharmaceuticals Industries Ltd. Xerostomia (Dry Mouth) Therapeutics Production Growth Rate (2012-2017)
Figure Sun Pharmaceuticals Industries Ltd. Xerostomia (Dry Mouth) Therapeutics Production Market Share (2012-2017)
Figure Sun Pharmaceuticals Industries Ltd. Xerostomia (Dry Mouth) Therapeutics Revenue Market Share (2012-2017)
Table Lupin Pharmaceuticals, Inc. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Lupin Pharmaceuticals, Inc. Xerostomia (Dry Mouth) Therapeutics Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Lupin Pharmaceuticals, Inc. Xerostomia (Dry Mouth) Therapeutics Production Growth Rate (2012-2017)
Figure Lupin Pharmaceuticals, Inc. Xerostomia (Dry Mouth) Therapeutics Production Market Share (2012-2017)
Figure Lupin Pharmaceuticals, Inc. Xerostomia (Dry Mouth) Therapeutics Revenue Market Share (2012-2017)
Table Pfizer, Inc. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Pfizer, Inc. Xerostomia (Dry Mouth) Therapeutics Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Pfizer, Inc. Xerostomia (Dry Mouth) Therapeutics Production Growth Rate (2012-2017)
Figure Pfizer, Inc. Xerostomia (Dry Mouth) Therapeutics Production Market Share (2012-2017)
Figure Pfizer, Inc. Xerostomia (Dry Mouth) Therapeutics Revenue Market Share (2012-2017)
Table Parnell Pharmaceuticals, Inc. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Parnell Pharmaceuticals, Inc. Xerostomia (Dry Mouth) Therapeutics Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Parnell Pharmaceuticals, Inc. Xerostomia (Dry Mouth) Therapeutics Production Growth Rate (2012-2017)
Figure Parnell Pharmaceuticals, Inc. Xerostomia (Dry Mouth) Therapeutics Production Market Share (2012-2017)
Figure Parnell Pharmaceuticals, Inc. Xerostomia (Dry Mouth) Therapeutics Revenue Market Share (2012-2017)
Table Acacia Pharma Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Acacia Pharma Xerostomia (Dry Mouth) Therapeutics Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Acacia Pharma Xerostomia (Dry Mouth) Therapeutics Production Growth Rate (2012-2017)
Figure Acacia Pharma Xerostomia (Dry Mouth) Therapeutics Production Market Share (2012-2017)
Figure Acacia Pharma Xerostomia (Dry Mouth) Therapeutics Revenue Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Xerostomia (Dry Mouth) Therapeutics
Figure Manufacturing Process Analysis of Xerostomia (Dry Mouth) Therapeutics
Figure Xerostomia (Dry Mouth) Therapeutics Industrial Chain Analysis
Table Raw Materials Sources of Xerostomia (Dry Mouth) Therapeutics Major Manufacturers in 2016
Table Major Buyers of Xerostomia (Dry Mouth) Therapeutics
Table Distributors/Traders List
Figure Global Xerostomia (Dry Mouth) Therapeutics Capacity, Production (K Units) and Growth Rate Forecast (2017-2022)
Figure Global Xerostomia (Dry Mouth) Therapeutics Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Global Xerostomia (Dry Mouth) Therapeutics Price (Million USD) and Trend Forecast (2017-2022)
Table Global Xerostomia (Dry Mouth) Therapeutics Production (K Units) Forecast by Region (2017-2022)
Figure Global Xerostomia (Dry Mouth) Therapeutics Production Market Share Forecast by Region (2017-2022)
Table Global Xerostomia (Dry Mouth) Therapeutics Consumption (K Units) Forecast by Region (2017-2022)
Figure Global Xerostomia (Dry Mouth) Therapeutics Consumption Market Share Forecast by Region (2017-2022)
Figure North America Xerostomia (Dry Mouth) Therapeutics Production (K Units) and Growth Rate Forecast (2017-2022)
Figure North America Xerostomia (Dry Mouth) Therapeutics Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table North America Xerostomia (Dry Mouth) Therapeutics Production, Consumption, Export and Import (K Units) Forecast (2017-2022)
Figure Europe Xerostomia (Dry Mouth) Therapeutics Production (K Units) and Growth Rate Forecast (2017-2022)
Figure Europe Xerostomia (Dry Mouth) Therapeutics Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Europe Xerostomia (Dry Mouth) Therapeutics Production, Consumption, Export and Import (K Units) Forecast (2017-2022)
Figure China Xerostomia (Dry Mouth) Therapeutics Production (K Units) and Growth Rate Forecast (2017-2022)
Figure China Xerostomia (Dry Mouth) Therapeutics Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table China Xerostomia (Dry Mouth) Therapeutics Production, Consumption, Export and Import (K Units) Forecast (2017-2022)
Figure Japan Xerostomia (Dry Mouth) Therapeutics Production (K Units) and Growth Rate Forecast (2017-2022)
Figure Japan Xerostomia (Dry Mouth) Therapeutics Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Japan Xerostomia (Dry Mouth) Therapeutics Production, Consumption, Export and Import (K Units) Forecast (2017-2022)
Figure Southeast Asia Xerostomia (Dry Mouth) Therapeutics Production (K Units) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Xerostomia (Dry Mouth) Therapeutics Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Southeast Asia Xerostomia (Dry Mouth) Therapeutics Production, Consumption, Export and Import (K Units) Forecast (2017-2022)
Figure India Xerostomia (Dry Mouth) Therapeutics Production (K Units) and Growth Rate Forecast (2017-2022)
Figure India Xerostomia (Dry Mouth) Therapeutics Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table India Xerostomia (Dry Mouth) Therapeutics Production, Consumption, Export and Import (K Units) Forecast (2017-2022)
Table Global Xerostomia (Dry Mouth) Therapeutics Production (K Units) Forecast by Type (2017-2022)
Figure Global Xerostomia (Dry Mouth) Therapeutics Production (K Units) Forecast by Type (2017-2022)
Table Global Xerostomia (Dry Mouth) Therapeutics Revenue (Million USD) Forecast by Type (2017-2022)
Figure Global Xerostomia (Dry Mouth) Therapeutics Revenue Market Share Forecast by Type (2017-2022)
Table Global Xerostomia (Dry Mouth) Therapeutics Price Forecast by Type (2017-2022)
Table Global Xerostomia (Dry Mouth) Therapeutics Consumption (K Units) Forecast by Application (2017-2022)
Figure Global Xerostomia (Dry Mouth) Therapeutics Consumption (K Units) Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Source